🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dose escalation phase 1 study of PARP inhibitor PF-01367338 in combination ...
Status
Completed
Location
Churchill Hospital
Start Date
2010-02
Trial ID
NCT01009190
Treatments Being Tested
The main purpose of this study is to look at the effectiveness, safety, and...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2017-09-05
Trial ID
NCT03140670
Treatments Being Tested
Investigators hypothesize that following first-line platinum based chemothe...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2019-03-28
Trial ID
NCT03639935
This is a Phase 1 open-label, dose-escalation, safety and pharmacokinetic s...
Status
Completed
Location
Division of Medical Oncology, Hyogo Cancer Center
Start Date
2018-02-06
Trial ID
NCT03499444
Treatments Being Tested
The purpose of this study is to assess pharmacokinetic concentrations of mu...
Status
Completed
Location
BioVirtus Research Site
Start Date
2016-04
Trial ID
NCT02740712
This is an open label, non-randomized, dose escalation and expansion Phase ...
Status
Completed
Location
University of California San Francisco
Start Date
2018-01-12
Trial ID
NCT03318445
Treatments Being Tested
This is a phase II study of rucaparib, a small molecule inhibitor poly (ade...
Status
Completed
Location
University of Minnesota
Start Date
2018-06-29
Trial ID
NCT03476798
Treatments Being Tested
This is a single arm Phase Ib/II, open label, safety, pharmacokinetic and e...
Status
Active Not Recruiting
Location
Helen Diller Family Comprehensive Cancer Center University of California San Francisco
Start Date
2020-04-03
Trial ID
NCT04253262
Treatments Being Tested
The study consists of a retrospective observational, multicenter study in w...
Status
Completed
Location
Hospital Torrecárdenas
Start Date
2020-07-29
Trial ID
NCT04539327
Treatments Being Tested
This research study is evaluating three drugs called Nivolumab, Bevacizumab...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2016-11-10
Trial ID
NCT02873962
Treatments Being Tested